Induction therapy with cetuximab plus docetaxel, cisplatin, and 5-fluorouracil (ETPF) in patients with resectable nonmetastatic stage III or IV squamous cell carcinoma of the oropharynx. A GERCOR phase II ECHO-07 study

Induction TPF regimen is a standard treatment option for squamous cell carcinoma (SCC) of the oropharynx. The efficacy and safety of adding cetuximab to induction TPF (ETPF) therapy was evaluated. Patients with nonmetastatic resectable stage III/IV SCC of the oropharynx were treated with weekly cetu...

Descripción completa

Detalles Bibliográficos
Autores principales: Chibaudel, Benoist, Lacave, Roger, Lefevre, Marine, Soussan, Patrick, Antoine, Martine, Périé, Sophie, Belloc, Jean-Baptiste, Banal, Alain, Albert, Sébastien, Chabolle, Frédéric, Céruse, Philippe, Baril, Philippe, Gatineau, Michel, Housset, Martin, Moukoko, Rachel, Benetkiewicz, Magdalena, de Gramont, Aimery, Bonnetain, Franck, Lacau St Guily, Jean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430265/
https://www.ncbi.nlm.nih.gov/pubmed/25684313
http://dx.doi.org/10.1002/cam4.408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430265/
https://www.ncbi.nlm.nih.gov/pubmed/25684313
http://dx.doi.org/10.1002/cam4.408

Ejemplares similares